PH-46A
CAS No. 1421332-97-9
PH-46A( PH 46A | PH46A )
Catalog No. M11761 CAS No. 1421332-97-9
A potent, first-in-class, oral small-molecule agent for the treatment of inflammatory bowel diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePH-46A
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, first-in-class, oral small-molecule agent for the treatment of inflammatory bowel diseases.
-
DescriptionA potent, first-in-class, oral small-molecule agent for the treatment of inflammatory bowel diseases.Ulcer Phase 1 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsPH 46A | PH46A
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research AreaOther Indications
-
IndicationUlcer
Chemical Information
-
CAS Number1421332-97-9
-
Formula Weight396.48
-
Molecular FormulaC27H24O3
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(OC)C1=CC=C(C[C@]2(C(C3)=CC4=C3C=CC=C4)[C@H](O)C5=C(C=CC=C5)C2)C=C1
-
Chemical NameBenzoic acid, 4-[[(1S,2S)-2,3-dihydro-1-hydroxy[2,2'-bi-1H-inden]-2-yl]methyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
SARM1-IN-2
SARM1-IN-2 is a potent SARM1 inhibitor for the study of metabolic and neurological related diseases.
-
Epcoritamab
Epcoritamab (GEN3013) is a novel subcutaneous CD3xCD20 bispecific T-cell binding antibody that activates T-cells and directs them to kill malignant CD20(+) B-cells for the study of relapsed or refractory large B-cell lymphoma.
-
Isovalerylshikonin
Compound is a useful organic compound for research related to life sciences.
Cart
sales@molnova.com